ACRV · Company research
Acrivon Therapeutics, Inc. Common Stock (ACRV): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Acrivon Therapeutics (ACRV) Grinds Higher: Micro-Cap Biotech Ticks Up 1.08% to $1.88 - Hidden Order - https://www.dars.gov.et/ | Acrivon Therapeutics (ACRV) Grinds Higher: Micro-Cap Biotech Ticks Up 1.08% to $1.88 - Hidden Order https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 8, 2026 | neutral | 0 | 0.6 |
| Automatic tax withholding triggers a 294-share sale by Acrivon Therapeutics (ACRV) legal chief - Stock Titan | Automatic tax withholding triggers a 294-share sale by Acrivon Therapeutics (ACRV) legal chief Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Acrivon Therapeutics (ACRV) Stock Analysis Report | Financials & Insights - Benzinga España | Acrivon Therapeutics (ACRV) Stock Analysis Report | Financials & Insights Benzinga España | View source ↗ | Benzinga España | Sep 27, 2026 | neutral | 0 | 0.6 |
| Pleasing Signs As A Number Of Insiders Buy Acrivon Therapeutics Stock - Simply Wall Street | Pleasing Signs As A Number Of Insiders Buy Acrivon Therapeutics Stock Simply Wall Street | View source ↗ | Simply Wall Street | Sep 16, 2026 | neutral | 0 | 0.6 |
| What Makes Acrivon Therapeutics, Inc. (ACRV) a New Buy Stock - Yahoo Finance | What Makes Acrivon Therapeutics, Inc. (ACRV) a New Buy Stock Yahoo Finance | View source ↗ | Yahoo Finance | Sep 15, 2026 | neutral | 0 | 0.6 |
| Acrivon (NASDAQ: ACRV) CEO may sell stock from vested RSUs - Stock Titan | Acrivon (NASDAQ: ACRV) CEO may sell stock from vested RSUs Stock Titan | View source ↗ | Stock Titan | Aug 25, 2026 | neutral | 0 | 0.6 |
| Here's Why Acrivon Therapeutics, Inc. (ACRV) is a Great Momentum Stock to Buy - Yahoo Finance | Here's Why Acrivon Therapeutics, Inc. (ACRV) is a Great Momentum Stock to Buy Yahoo Finance | View source ↗ | Yahoo Finance | Aug 24, 2026 | neutral | 0 | 0.6 |
| $ACRV stock is up 9% today. Here's what we see in our data. - Quiver Quantitative | $ACRV stock is up 9% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 17, 2026 | neutral | 0 | 0.6 |
| Trading Systems Reacting to (ACRV) Volatility - Stock Traders Daily | Trading Systems Reacting to (ACRV) Volatility Stock Traders Daily | View source ↗ | Stock Traders Daily | Jul 15, 2026 | neutral | 0 | 0.6 |
| Acrivon Therapeutics: Priced For Failure, Built For Precision (NASDAQ:ACRV) - Seeking Alpha | Acrivon Therapeutics: Priced For Failure, Built For Precision (NASDAQ:ACRV) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 13, 2026 | neutral | 0 | 0.6 |
| ACRV Forecast — Price Target — Prediction for 2027 - TradingView | ACRV Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Acrivon Therapeutics CEO Blume-Jensen buys $82k in shares - Investing.com | Acrivon Therapeutics CEO Blume-Jensen buys $82k in shares Investing.com | View source ↗ | Investing.com | Jan 16, 2026 | neutral | 0 | 0.6 |
| Acrivon Therapeutics Inc.: Rise or Retreat? - StocksToTrade | Acrivon Therapeutics Inc.: Rise or Retreat? StocksToTrade | View source ↗ | StocksToTrade | Jan 8, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Apr 2, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.